Sagimet Biosciences Inc. - Seri
SGMT
Jodie situation report
Sagimet Biosciences Inc. - Seri's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 12 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- SGMT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if SGMT's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind SGMT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
PFEPfizer, Inc.partnerMar 11, 2026 ▾
“Pfizer Inc.”
TEVATeva Pharmaceutical Industries LimitedpartnerMar 11, 2026 ▾
“In December 2025, we entered into a license agreement with Assia Chemical Industries Ltd., doing business as TAPI Technology & API Services (TAPI), a subsidiary of Teva Pharmaceutical Industries Ltd.”
PFEPfizer, Inc.competitorMar 11, 2026 ▾
“Our competitors include multinational pharmaceutical companies, specialized biotechnology companies and universities and other research institutions, including Altimmune, Inc., AstraZeneca, Boehringer Ingelheim and Zealand Pharma, Eli Lilly and Company, Galme…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
SGMT is currently a Follower in the organic co-movement group Biotechnology Innovators. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for SGMT; it is not active in the latest market snapshot.